MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 9, Pages 3084
Publisher
MDPI AG
Online
2020-04-28
DOI
10.3390/ijms21093084
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification and evolutionary analysis of polycistronic miRNA clusters in domesticated and wild wheat
- (2020) Amit Kumar Singh et al. GENOMICS
- Communication in tiny packages: Exosomes as means of tumor-stroma communication
- (2020) Juliane Daßler-Plenker et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
- (2020) David S. Hong et al. BRITISH JOURNAL OF CANCER
- The Potential for microRNA Therapeutics and Clinical Research
- (2019) Johora Hanna et al. Frontiers in Genetics
- High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment
- (2019) Antonio Giovanni Solimando et al. Journal of Clinical Medicine
- The Role and Function of microRNA in the Pathogenesis of Multiple Myeloma
- (2019) Hiroshi Handa et al. Cancers
- Lipid nanocarriers for microRNA delivery
- (2019) Marcel Scheideler et al. CHEMISTRY AND PHYSICS OF LIPIDS
- The AGO proteins: an overview
- (2018) Saife Niaz BIOLOGICAL CHEMISTRY
- Treating cancer with microRNA replacement therapy: A literature review
- (2018) Nayer Hosseinahli et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Anti-miRNA oligonucleotides: A comprehensive guide for design
- (2018) Joana Filipa Lima et al. RNA Biology
- The potential function of microRNAs as biomarkers and therapeutic targets in multiple myeloma (Review)
- (2018) Bingying Zhu et al. Oncology Letters
- The diagnostic and prognostic value of plasma microRNA‑125b‑5p in patients with multiple myeloma
- (2018) Yanxia Jiang et al. Oncology Letters
- The expression and role of miR-181a in multiple myeloma
- (2018) Ruili Yuan et al. MEDICINE
- Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
- (2018) Jacob O'Brien et al. Frontiers in Endocrinology
- Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes
- (2018) Maria Antonia Frassanito et al. JOURNAL OF PATHOLOGY
- Response commentary: exosomes vs microvesicles in hematological malignancies
- (2017) T L Whiteside et al. LEUKEMIA
- MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells
- (2017) C Botta et al. LEUKEMIA
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Global miRNA expression analysis identifies novel key regulators of plasma cell differentiation and malignant plasma cell
- (2017) Alboukadel Kassambara et al. NUCLEIC ACIDS RESEARCH
- Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment
- (2017) Mayra Rachele Zarone et al. Scientific Reports
- Exosomes and other extracellular vesicles-mediated microRNA delivery for cancer therapy
- (2017) Giuliana Di Rocco et al. Translational Cancer Research
- Effect of surface properties on liposomal siRNA delivery
- (2016) Yuqiong Xia et al. BIOMATERIALS
- Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity
- (2016) Kim De Veirman et al. CANCER LETTERS
- OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer
- (2016) Alexander A. Svoronos et al. CANCER RESEARCH
- Integrative analysis of signaling pathways and diseases associated with the miR-106b/25 cluster and their function study in berberine-induced multiple myeloma cells
- (2016) Chunming Gu et al. FUNCTIONAL & INTEGRATIVE GENOMICS
- Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
- (2016) Muhammad S. Beg et al. INVESTIGATIONAL NEW DRUGS
- The LIN28B/let-7 axis is a novel therapeutic pathway in multiple myeloma
- (2016) S Manier et al. LEUKEMIA
- Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma
- (2016) Nicola Amodio et al. MOLECULAR CANCER THERAPEUTICS
- Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer
- (2016) Glen Reid et al. Epigenomics
- Microenvironment drug resistance in multiple myeloma: emerging new players
- (2016) Lucia Di Marzo et al. Oncotarget
- Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma
- (2016) Li Zhang et al. Oncotarget
- MiR-10b decreases sensitivity of glioblastoma cells to radiation by targeting AKT
- (2016) Limin Zhen et al. Journal of Biological Research-Thessaloniki
- miRNAs in pancreatic cancer: Therapeutic potential, delivery challenges and strategies
- (2015) Deepak Chitkara et al. ADVANCED DRUG DELIVERY REVIEWS
- In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
- (2015) Yunching Chen et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma
- (2015) J.-J. Zhao et al. CANCER RESEARCH
- A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells
- (2015) A. Gulla et al. CLINICAL CANCER RESEARCH
- Ultrasound-guided delivery of microRNA loaded nanoparticles into cancer
- (2015) Tzu-Yin Wang et al. JOURNAL OF CONTROLLED RELEASE
- Simultaneous Drug and Gene Delivery from the Biodegradable Poly(-caprolactone) Nanofibers for the Treatment of Liver Cancer
- (2015) Hui-Lian Che et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo
- (2015) E Morelli et al. LEUKEMIA
- MicroRNA-34c targets TGFB-induced factor homeobox 2, represses cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma
- (2015) YAN WANG et al. Oncology Letters
- Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma
- (2015) Donato Cosco et al. Scientific Reports
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatment
- (2015) Lin Kang et al. Acta Pharmaceutica Sinica B
- DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma
- (2015) Nicola Amodio et al. Oncotarget
- Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages
- (2014) Giuseppina Turturici et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Long chain microRNA conjugates in calcium phosphate nanoparticles for efficient formulation and delivery
- (2014) Hyosook Jung et al. ARCHIVES OF PHARMACAL RESEARCH
- Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer
- (2014) Masaki Mori et al. CELL
- The complexity of miRNA-mediated repression
- (2014) A Wilczynska et al. CELL DEATH AND DIFFERENTIATION
- A p53-Dependent Tumor Suppressor Network Is Induced by Selective miR-125a-5p Inhibition in Multiple Myeloma Cells
- (2014) Marzia Leotta et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: Current progress and advances
- (2014) Nishant S. Gandhi et al. JOURNAL OF CONTROLLED RELEASE
- Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression
- (2014) Sanjun Shi et al. JOURNAL OF CONTROLLED RELEASE
- MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomib
- (2014) S Jagannathan et al. LEUKEMIA
- Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy
- (2014) Carla L Esposito et al. MOLECULAR THERAPY
- miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2
- (2014) Jing Y. Krzeszinski et al. NATURE
- Regulation of microRNA biogenesis
- (2014) Minju Ha et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras
- (2014) Zhumei Shi et al. NEURO-ONCOLOGY
- In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma
- (2014) Maria Teresa Di Martino et al. PLoS One
- Endogenous RNAs Modulate MicroRNA Sorting to Exosomes and Transfer to Acceptor Cells
- (2014) Mario Leonardo Squadrito et al. Cell Reports
- Mir-34: A New Weapon Against Cancer?
- (2014) Gabriella Misso et al. Molecular Therapy-Nucleic Acids
- Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth
- (2013) Mark Katakowski et al. CANCER LETTERS
- Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth
- (2013) E. Leone et al. CLINICAL CANCER RESEARCH
- Nanoparticle-mediated delivery of therapeutic genes: focus on miRNA therapeutics
- (2013) Muthunarayanan Muthiah et al. Expert Opinion on Drug Delivery
- Sustained delivery of proangiogenic microRNA-132 by nanoparticle transfection improves endothelial cell transplantation
- (2013) Julie Devalliere et al. FASEB JOURNAL
- BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression
- (2013) Aldo M. Roccaro et al. JOURNAL OF CLINICAL INVESTIGATION
- Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations
- (2013) Xinmei Wang et al. JOURNAL OF CONTROLLED RELEASE
- Progress in microRNA delivery
- (2013) Yu Zhang et al. JOURNAL OF CONTROLLED RELEASE
- MicroRNA theragnostics for the clinical management of multiple myeloma
- (2013) N Ahmad et al. LEUKEMIA
- Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer
- (2013) Yun Wu et al. Molecular Therapy-Nucleic Acids
- miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF
- (2012) Chun-Yan Sun et al. CARCINOGENESIS
- MicroRNAs in the Pathobiology of Multiple Myeloma
- (2012) Marta Lionetti et al. CURRENT CANCER DRUG TARGETS
- Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma
- (2012) P. Tagliaferri et al. CURRENT CANCER DRUG TARGETS
- MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
- (2012) Marilena V. Iorio et al. EMBO Molecular Medicine
- miR-29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma-related bone disease
- (2012) Marco Rossi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Sequence-Dependent Synergistic Inhibition of Human Glioma Cell Lines by Combined Temozolomide and miR-21 Inhibitor Gene Therapy
- (2012) Xiaomin Qian et al. MOLECULAR PHARMACEUTICS
- The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC
- (2012) Marc R Fabian et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma
- (2012) I. A. Babar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1
- (2012) N Amodio et al. Cell Death & Disease
- Pathogenesis of Myeloma
- (2011) Kenneth C. Anderson et al. Annual Review of Pathology-Mechanisms of Disease
- Overexpression of microRNA-29b induces apoptosis of multiple myeloma cells through down regulating Mcl-1
- (2011) Yi-Kun Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Deregulated microRNAs in multiple myeloma
- (2011) Leonidas Benetatos et al. CANCER
- miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma
- (2011) Lijuan Chen et al. CANCER LETTERS
- MicroRNA Replacement Therapy for miR-145 and miR-33a Is Efficacious in a Model of Colon Carcinoma
- (2011) A. F. Ibrahim et al. CANCER RESEARCH
- Developing therapeutic microRNAs for cancer
- (2011) A G Bader et al. GENE THERAPY
- Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation
- (2011) Xudong Wang et al. LEUKEMIA & LYMPHOMA
- MicroRNA Delivery by Cationic Lipoplexes for Lung Cancer Therapy
- (2011) Yun Wu et al. MOLECULAR PHARMACEUTICS
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
- (2011) Can Liu et al. NATURE MEDICINE
- MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer
- (2011) M V Geraldo et al. ONCOGENE
- Horizontal transfer of RNAs: exosomes as mediators of intercellular communication
- (2011) Saraswathi Ramachandran et al. Wiley Interdisciplinary Reviews-RNA
- MicroRNA Profiles of Drug-Resistant Myeloma Cell Lines
- (2010) Reinhold Munker et al. ACTA HAEMATOLOGICA
- Epigenetic inactivation of the miR-34a in hematological malignancies
- (2010) C.S. Chim et al. CARCINOGENESIS
- The widespread regulation of microRNA biogenesis, function and decay
- (2010) Jacek Krol et al. NATURE REVIEWS GENETICS
- Structure and activity of putative intronic miRNA promoters
- (2010) A. M. Monteys et al. RNA
- Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma
- (2009) M. Lionetti et al. BLOOD
- MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma
- (2009) A. M. Roccaro et al. BLOOD
- SnapShot: MicroRNAs in Cancer
- (2009) Riccardo Spizzo et al. CELL
- Causes and consequences of microRNA dysregulation in cancer
- (2009) Carlo M. Croce NATURE REVIEWS GENETICS
- E2F1-Regulated MicroRNAs Impair TGFβ-Dependent Cell-Cycle Arrest and Apoptosis in Gastric Cancer
- (2008) Fabio Petrocca et al. CANCER CELL
- Phase I Clinical Trial of Autologous Ascites-derived Exosomes Combined With GM-CSF for Colorectal Cancer
- (2008) Shengming Dai et al. MOLECULAR THERAPY
- MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
- (2008) F. Pichiorri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- let-7 microRNAs in development, stem cells and cancer
- (2008) Ingo Büssing et al. TRENDS IN MOLECULAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started